Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 3 |
2022 | 3 |
2023 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean
mewshaw r[au]
(32 results)?
Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic Agent.
J Med Chem. 2022 Nov 24;65(22):15358-15373. doi: 10.1021/acs.jmedchem.2c01331. Epub 2022 Nov 11.
J Med Chem. 2022.
PMID: 36368007
Free PMC article.
Effective Treatment of Human Breast Carcinoma Xenografts with Single-Dose 211At-Labeled Anti-HER2 Single-Domain Antibody Fragment.
Feng Y, Meshaw R, Zhao XG, Jannetti S, Vaidyanathan G, Zalutsky MR.
Feng Y, et al. Among authors: meshaw r.
J Nucl Med. 2023 Jan;64(1):124-130. doi: 10.2967/jnumed.122.264071. Epub 2022 May 26.
J Nucl Med. 2023.
PMID: 35618478
Free PMC article.
Item in Clipboard
Site-Specific and Residualizing Linker for 18F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment.
Zhou Z, Meshaw R, Zalutsky MR, Vaidyanathan G.
Zhou Z, et al. Among authors: meshaw r.
J Nucl Med. 2021 Nov;62(11):1624-1630. doi: 10.2967/jnumed.120.261446. Epub 2021 Feb 26.
J Nucl Med. 2021.
PMID: 33637584
Free PMC article.
Item in Clipboard
Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agent.
Feng Y, Zhou Z, McDougald D, Meshaw RL, Vaidyanathan G, Zalutsky MR.
Feng Y, et al. Among authors: meshaw rl.
Nucl Med Biol. 2021 Jan;92:171-183. doi: 10.1016/j.nucmedbio.2020.05.002. Epub 2020 May 12.
Nucl Med Biol. 2021.
PMID: 32448731
Free PMC article.
Item in Clipboard
Evaluation of an 131I-labeled HER2-specific single domain antibody fragment for the radiopharmaceutical therapy of HER2-expressing cancers.
Feng Y, Meshaw R, McDougald D, Zhou Z, Zhao XG, Jannetti SA, Reiman RE, Pippen E, Marjoram R, Schaal JL, Vaidyanathan G, Zalutsky MR.
Feng Y, et al. Among authors: meshaw r.
Sci Rep. 2022 Feb 22;12(1):3020. doi: 10.1038/s41598-022-07006-9.
Sci Rep. 2022.
PMID: 35194100
Free PMC article.
Item in Clipboard
Labeling single domain antibody fragments with 18F using a novel residualizing prosthetic agent - N-succinimidyl 3-(1-(2-(2-(2-(2-[18F]fluoroethoxy)ethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)-5-(guanidinomethyl)benzoate.
Zhou Z, McDougald D, Meshaw R, Balyasnikova I, Zalutsky MR, Vaidyanathan G.
Zhou Z, et al. Among authors: meshaw r.
Nucl Med Biol. 2021 Sep-Oct;100-101:24-35. doi: 10.1016/j.nucmedbio.2021.06.002. Epub 2021 Jun 11.
Nucl Med Biol. 2021.
PMID: 34146837
Free PMC article.
Item in Clipboard
Cite
Cite